Premium
Severe asthma: implementing game‐changing science
Author(s) -
Gibson Peter G
Publication year - 2018
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja18.00477
Subject(s) - citation , library science , art history , sociology , history , computer science
John Hunter Hospital, Newcastle, N Podcast with Peter Gibson availab t’s been a long time coming, but I feel great now.” “I feel “Ilike I’ve got my life back.” These are statements made by patients with severe asthma who have had positive responses to targeted monoclonal antibody therapy for asthma. Both patients have severe refractory eosinophilic asthma and have experienced many years of persistent symptoms despite daily maintenance prednisone. On monoclonal antibody therapy, they achieved complete symptom control and significant prednisone reduction.